Profile
ACER VRTX REGN VRNA ARGX ALNY
Company Name Acer Therapeutics Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap - $122.53B $77.39B $72.68B $53.49B $46.18B
Employees 0.03K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Christopher Schelling Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
ACER VRTX REGN VRNA ARGX ALNY
Quant Rating Score 3 4 4 1 4 3
Quant Rating Neutral Buy Buy Strong Sell Buy Neutral
Trading
ACER VRTX REGN VRNA ARGX ALNY
Last Close $0.6601 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $0.9 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.66 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -26.66 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 0.02 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
ACER VRTX REGN VRNA ARGX ALNY
1 Month Return 0 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 0 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 0 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 0 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 0 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -26.66 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ACER VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -176.74 % 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Profitability
ACER VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM - 86.28 % 85.39 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -225.71 % 14.78 % 11.4 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 283.88 % 21.81 % 15.31 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM 335.91 % 19.59 % 10.32 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 88.98 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 106.59 % 111.4 % 139.5 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM - 34.06 % 25.89 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -254.98 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.51 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.3 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.64 0.94 2.26 6.82
Fixed Asset Turnover TTM - 388.59 % 284.82 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM - 47.15 % 35.47 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -1.92 14.55 48.94 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -1.93 13.06 40.09 -0.85 5.58 1.68
Cash Per Share TTM 14.77 % 2459.7 % 8148.65 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM - 31.71 % 35.59 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.57 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -254.98 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM - 36.72 18.63 -995.27 134.41 208.64
Price To Operating Cash Flows Ratio TTM -0.34 32.85 15.31 -126.33 151.74 172.84
Price Cash Flow Ratio TTM -0.34 32.85 15.31 -126.33 151.74 172.84
Income Statement (TTM)
ACER VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.2B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.23B $0.03B $1.96B $1.92B
Gross Profit Ratio 0% 86.11% 86.13% 93.89% 89.62% 85.62%
EBITDA $-0.02B $0.49B $5.32B $-0.12B $0.11B $-0.18B
Net Income $-0.03B $-0.54B $4.41B $-0.14B $0.83B $-0.28B
EPS Diluted -1.77 -2.08 38.34 -1.73 12.78 -2.18
Balance Sheet (MRQ)
ACER VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.01B $1.66B $2.7B $0.12B $0.03B $2.59B
Total Liabilities $0.03B $6.12B $8.41B $0.27B $0.7B $4.17B
Total Equity $-0.02B $16.41B $29.35B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $0.02B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.7B $0.12B $0.04B $2.74B
Total Assets $0.01B $22.53B $37.76B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
ACER VRTX REGN VRNA ARGX ALNY
Net Income $-0.03B $-0.54B $4.41B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 25.14
AARD Aardvark Therapeutics, Inc. Common Stock 13.3
ABCL AbCellera Biologics Inc. 3.87
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.075
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.7779
ABPWW 0.0139
ABSI Absci Corporation 3.0344
ABUS Arbutus Biopharma Corporation 4.1232
ABVC ABVC BioPharma, Inc. 2.08
ABVX Abivax SA American Depositary Shares 113.62
ACAD ACADIA Pharmaceuticals Inc. 25.71
ACET Adicet Bio, Inc. 8.44
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.365
ACIU AC Immune SA 3.4
ACLX Arcellx, Inc. 68.275
ETFs With Exposure to ACER
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 342.325
ITOT iShares Core S&P Total U.S. Stock Market ETF 0 151.76
IWC iShares Micro-Cap ETF 0.0034 169.93
ACSG Xtrackers MSCI ACWI ex USA ESG Leaders Equity ETF 0.03 42.41
Unlock